Comparing Paroxetine and Duloxetine on Cardiovascular Measures
NCT00136383 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2014-07-21
Summary
This double-blind placebo-controlled trial is designed to test and to compare the cardiovascular profile of paroxetine controlled release (CR) with duloxetine in outpatients with depressive symptoms.
Conditions
- Depressive Symptoms
Interventions
- DRUG
-
paroxetine versus duloxetine
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Wei Zhang, M.D., Ph.D. · Duke University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-03-31
- Completion
- 2007-06-30
Countries
- United States
Study Locations
More Related Trials
-
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
NCT00122837 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Depression and Associated Painful Physical Symptoms
NCT01070329 ·Status: COMPLETED ·Phase: PHASE4
-
Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder
NCT00122824 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder
NCT00122863 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine vs. Active Comparator in the Treatment of Patients With Depression
NCT00071695 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effects of Duloxetine on Norepinephrine
NCT00414323 ·Status: COMPLETED ·Phase: PHASE1
-
Duloxetine vs. Active Comparator for the Treatment of Depression
NCT00067912 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Use Investigation for PAXIL Tablet
NCT01371435 ·Status: COMPLETED
-
Study of Duloxetine in Elderly Patients With Major Depressive Disorder
NCT00062673 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder
NCT00105989 ·Status: COMPLETED ·Phase: PHASE3
-
Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain
NCT00036335 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
NCT00122850 ·Status: COMPLETED ·Phase: PHASE3
-
A Local Register Study For Major Depression Of Paroxetine Controlled Release
NCT00368303 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
NCT00048204 ·Status: COMPLETED ·Phase: PHASE2
-
Switching to Duloxetine in Patients With Depression
NCT00696774 ·Status: COMPLETED ·Phase: PHASE4
-
Special Drug Use Investigation for PAXIL Tablet (Long-term)
NCT01371448 ·Status: COMPLETED
-
Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression
NCT02229825 ·Status: COMPLETED ·Phase: PHASE4
-
Desvenlafaxine vs. Placebo Treatment of Chronic Depression
NCT01537068 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
NCT07300969 ·Status: RECRUITING ·Phase: PHASE2
-
Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects
NCT01318031 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
NCT00413023 ·Status: COMPLETED ·Phase: PHASE2
-
An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
NCT00629551 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerability and Safety of Duloxetine BID in Healthy Female Subjects
NCT02232542 ·Status: COMPLETED ·Phase: PHASE1
-
Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)
NCT01371461 ·Status: COMPLETED
-
An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder
NCT00057213 ·Status: COMPLETED ·Phase: PHASE2